Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Albi

9 clinical trials in Albi, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Albi at a glance
9
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Albi

Open in trial search

Testing sacituzumab govitecan and trastuzumab deruxtecan in alternating pattern for patients with HER2-low triple-negative breast cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sacituzumab Govitecan
  • Sponsor:Unicancer

Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Levofolinate
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Study on Olaparib for Patients with p53abn Endometrial Cancer After Chemoradiation Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Institut Gustave Roussy

Study Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Colon cancer

Not recruiting

Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive

Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Unicancer

Prostate cancer

Not recruiting

Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Leuprorelin Acetate
  • Sponsor:Unicancer

Bartonellosis

Not recruiting

Study on Gentamicin and Azithromycin for Treating Lymph Node Infection in Cat Scratch Disease Patients

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azithromycin
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Breast cancer female

Not recruiting

Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Unicancer

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Albi

What the registry says about research in the country

01 Oncology - Gynecologic Cancers

Innovative research focusing on endometrial cancer treatment optimization, specifically evaluating maintenance therapy approaches after chemoradiotherapy in patients with specific molecular features.

  • Molecular-based treatment strategies
  • Post-surgical therapy optimization
  • Recurrence prevention protocols

Studies aim to improve survival outcomes through targeted therapeutic approaches.

02 Gastrointestinal Oncology

Clinical investigations examining treatment options for small bowel adenocarcinoma, comparing different chemotherapy regimens for advanced or metastatic cases.

  • Advanced disease management
  • Progression-free survival assessment
  • Comparative treatment efficacy

Research focuses on determining optimal treatment protocols for rare intestinal cancers.

03 Breast Cancer Research

Studies evaluating personalized treatment approaches for hormone receptor-positive breast cancer, particularly in elderly patients and those with high relapse risk.

  • Age-specific treatment protocols
  • Hormone therapy optimization
  • Genomic-guided treatment decisions

Investigations aim to refine treatment strategies based on molecular characteristics and patient age.

04 Infectious Diseases

Novel treatment approaches for cat scratch disease lymphadenitis, examining the effectiveness of targeted antibiotic delivery methods.

  • Innovative treatment delivery
  • Antibiotics efficacy studies
  • Disease-specific interventions

Research focuses on improving treatment outcomes for specific bacterial infections.

05 Urologic Oncology

Research evaluating long-term hormonal treatment strategies for high-risk prostate cancer following radical surgery.

  • Post-surgical hormone therapy
  • Recurrence prevention
  • Long-term survival outcomes

Studies aim to optimize adjuvant treatment protocols for improved patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.